REFERENCES
Brodie MJ: Lamotrigine. Lancet 339:1397-1400, 1992
Besag FM, Wallace SI, Dulac O, Alving J, Spencer SC, Hosking G: Lamotrigine for the treatment of epilepsy in childhood. J Pediatr 127:991-997, 1995
Buchanan N: The efficacy of lamotrigine on seizure control in 34 children, adolescents and young adults with intellectual and physical disability. Seizure 4:233-236, 1995
Motte J, Trevathan E, Arvidsson JFV, Nieto Barrera M, Mullens LE, Manasco P, et al: Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. N Engl J Med 337:1807-1812, 1997
Betts T, Goodwin G, Withers RM, Yuen AWC: Human safety of lamotrigine. Epilepsia 32(suppl. 2):S17-S22, 1991
Yuen AWC: Multiorgan failure and disseminated intravascular coagulation in severe convulsive seizures. Lancet 340:618, 1992
Shaub JEM, Williamson PJ, Barnes EW, Trewby PN: Multisystem adverse reaction to lamotrigine. Lancet 344:481, 1994
Makin AJ, Fitt S, Williams R, Duncan JS: Fulminant hepatitis failure induced by lamotrigine. BMJ 311:292, 1995
Arnon R, De Vivo D, Defelice AR, Kazlow PG: Acute hepatic failure in a child treated with lamotrigine. Pediatr Neurol 18:251-252, 1994
Danan G: Définitions et critères d'imputation des atteintes hépatiques aiguës médicamenteuses. Conclusions d'une réunion internationale de consensus. Gastroenterol Clin Biol 17:H18-H22, 1993
Betts T: Clinical uses of lamotrigine. Seizure 1:3-6, 1992
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sauvé, G., Bresson-Hadni, S., Prost, P. et al. CASE REPORT: Acute Hepatitis After Lamotrigine Administration. Dig Dis Sci 45, 1874–1877 (2000). https://doi.org/10.1023/A:1005593119425
Issue Date:
DOI: https://doi.org/10.1023/A:1005593119425